Literature DB >> 12878271

Prenatal exposure to ethanol increases ethanol consumption: a conditioned response?

M Gabriela Chotro1, Carlos Arias.   

Abstract

Administration of a moderate dose (2 g/kg) of ethanol to the pregnant rat during the last days of gestation (17-20) has been observed to increase the offspring's ethanol consumption on postnatal day 14. This effect was not observed with a 1-g/kg dose (Experiment 1a). When pups were tested during adolescence (day 28) an augmented ethanol intake was observed in female rats exposed to the low dose of ethanol and in male rats exposed to the moderate one (Experiment 1b). The effect of increased ethanol intake in preweanling rats was reduced after naloxone was administered, together with ethanol, to the pregnant dam (Experiment 2). Postnatal reexposure to ethanol, together with a naloxone injection, also decreased ethanol intake in pups exposed prenatally to the drug (Experiment 3). All these results seem to support the hypothesis of a conditioned preference learned in utero as a consequence of the association between the orosensory characteristics of ethanol and its reinforcing properties, apparently mediated by the opioid system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12878271     DOI: 10.1016/s0741-8329(03)00037-5

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  45 in total

1.  Participation of the endogenous opioid system in the acquisition of a prenatal ethanol-related memory: effects on neonatal and preweanling responsiveness to ethanol.

Authors:  R Sebastián Miranda-Morales; Juan Carlos Molina; Norman E Spear; Paula Abate
Journal:  Physiol Behav       Date:  2010-05-06

2.  Period 2 gene deletion abolishes beta-endorphin neuronal response to ethanol.

Authors:  Maria Agapito; Nadia Mian; Nadka I Boyadjieva; Dipak K Sarkar
Journal:  Alcohol Clin Exp Res       Date:  2010-06-25       Impact factor: 3.455

3.  Endogenous opioids as substrates for ethanol intake in the neonatal rat: The impact of prenatal ethanol exposure on the opioid family in the early postnatal period.

Authors:  Kelly Bordner; Terrence Deak
Journal:  Physiol Behav       Date:  2015-02-07

4.  Naloxone attenuation of ethanol-reinforced operant responding in infant rats in a re-exposure paradigm.

Authors:  Roberto Sebastián Miranda-Morales; Juan Carlos Molina; Norman E Spear; Paula Abate
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

5.  Prenatal ethanol exposure attenuates sensitivity to the aversive effects of ethanol in adolescence and increases adult preference for a 5% ethanol solution in males, but not females.

Authors:  Jonathan Kent Gore-Langton; Linda Patia Spear
Journal:  Alcohol       Date:  2018-12-29       Impact factor: 2.405

6.  New evidence of ethanol's anxiolytic properties in the infant rat.

Authors:  Roberto Sebastián Miranda-Morales; Michael E Nizhnikov; Dustin H Waters; Norman E Spear
Journal:  Alcohol       Date:  2014-04-08       Impact factor: 2.405

7.  Central reinforcing effects of ethanol are blocked by catalase inhibition.

Authors:  Michael E Nizhnikov; Juan C Molina; Norman E Spear
Journal:  Alcohol       Date:  2007-11       Impact factor: 2.405

8.  Ontogeny of the enhanced fetal-ethanol-induced behavioral and neurophysiologic olfactory response to ethanol odor.

Authors:  Amber M Eade; Paul R Sheehe; Steven L Youngentob
Journal:  Alcohol Clin Exp Res       Date:  2009-11-24       Impact factor: 3.455

9.  Differential role of mu, delta and kappa opioid receptors in ethanol-mediated locomotor activation and ethanol intake in preweanling rats.

Authors:  Carlos Arias; Juan Carlos Molina; Norman E Spear
Journal:  Physiol Behav       Date:  2009-11-30

10.  The consequence of fetal ethanol exposure and adolescent odor re-exposure on the response to ethanol odor in adolescent and adult rats.

Authors:  Amber M Eade; Paul R Sheehe; Juan C Molina; Norman E Spear; Lisa M Youngentob; Steven L Youngentob
Journal:  Behav Brain Funct       Date:  2009-01-15       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.